Physician

Young-Ki Paik, M.D.

According to 2025 Medicare claims, Young-Ki Paik, M.D. (NPI: 1437314614) practices internal medicine in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is FRANCISCAN MEDICAL GROUP (NPI: 1710432612; TIN: 911939739) and primary practice location at 98366-3774. Paik is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Paik's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 461 traditional Medicare patients, billed 6,596 HCPCS/CPT codes, and received $279,704 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 7,482 prescription claims across 458 beneficiaries totaling $565,459 in drug costs, led by Eliquis (Apixaban). DME data shows 48 claims. Open Payments data shows 2 records totaling $37. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $153,851 to $565,459. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $7,569 and ending at $6,659.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	486	5,774	$168,940
2016	553	6,762	$209,742
2017	636	8,723	$232,229
2018	604	7,608	$204,674
2019	587	5,357	$251,435
2020	623	5,148	$220,688
2021	579	5,164	$243,871
2022	542	4,464	$216,609
2023	499	5,135	$262,054
2024	461	6,596	$279,704

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	215	3,258	$153,851
2016	260	4,014	$190,778
2017	319	4,799	$252,200
2018	317	5,008	$271,350
2019	339	5,571	$286,789
2020	417	6,402	$341,635
2021	418	6,143	$352,229
2022	442	5,890	$367,830
2023	398	6,130	$444,100
2024	458	7,482	$565,459

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	53	163	$3,162
2016	64	279	$4,401
2017	65	195	$1,585
2018	65	264	$4,385
2019	45	218	$3,737
2020	33	237	$5,020
2021	49	140	$1,997
2022	26	179	$4,492
2023	21	93	$2,584
2024	16	48	$417

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	315	315	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	458	1,808	$88
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	421	1,263	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	43	45	$10
96127	Assessment of emotional or behavioral problems	83	235	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	80	5,135	$97,261
Jardiance	Empagliflozin	61	3,750	$71,361
Xarelto	Rivaroxaban	51	3,393	$62,136
Rybelsus	Semaglutide	26	1,440	$42,313
Ozempic	Semaglutide	18	1,406	$40,671

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	16	37	$306
E0149	Walker, heavy duty, wheeled, rigid or folding, any type	Y	N/R	11	$110

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$37	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Young-Ki Paik, M.D.?

Tedicare shows public-source Medicare data for Young-Ki Paik, M.D. (NPI 1437314614), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Young-Ki Paik, M.D. have ACO affiliation data?

Young-Ki Paik, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Young-Ki Paik, M.D.?

Young-Ki Paik, M.D. is linked to FRANCISCAN MEDICAL GROUP (billing NPI 1710432612) in the available physician profile data.

Does Young-Ki Paik, M.D. have Open Payments data?

Young-Ki Paik, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.